Joseph A. Sorge
About
In The Last Decade
Joseph A. Sorge
54 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Molecular Biology 3.2k
- Genetics 1.1k
- Physiology 809
- Cell Biology 609
- Cancer Research 517
Countries citing papers authored by Joseph A. Sorge
This map shows the geographic impact of Joseph A. Sorge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. Sorge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. Sorge more than expected).
Fields of papers citing papers by Joseph A. Sorge
This network shows the impact of papers produced by Joseph A. Sorge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. Sorge. The network helps show where Joseph A. Sorge may publish in the future.
Co-authorship network of co-authors of Joseph A. Sorge
This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. Sorge. A scholar is included among the top collaborators of Joseph A. Sorge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. Sorge. Joseph A. Sorge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR | British Journal of Cancer | Lars Dyrskjøt, Thomas Reinert et al. | 27 |
| 2 | Computational Principles of Primer Design for Site Directed Mutagenesis | TechConnect Briefs | Alexey Novoradovsky, Vivian Zhang et al. | 8 |
| 3 | Amplification efficiency of thermostable DNA polymerases | Analytical Biochemistry | Bahram Arezi, Weimei Xing et al. | 121 |
| 4 | Hepatocarcinogenesis (Z#2)/mutagenesis during initiation stage | Mutation research. Fundamental and molecular mechanisms of mutagenesis | W. Stephen Nichols, Stephen A. Geller et al. | 4 |
| 5 | Creating seamless junctions independent of restriction sites in PCR cloning | Gene | Joseph A. Sorge et al. | 69 |
| 6 | Cloning in a bacteriophage lambda vector for the display of binding proteins on filamentous phage | Gene | Holly H. Hogrefe, Beverly N. Hay et al. | 13 |
| 7 | [42] pBluescriptII: Multifunctional cloning and mapping vectors | Methods in enzymology on CD-ROM/Methods in enzymology | Michelle A. Alting-Mees, Joseph A. Sorge et al. | 59 |
| 8 | High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosus | Gene | Michael W. W. Adams, Jay M. Short et al. | 414 |
| 9 | Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacl shuttle vector | Environmental and Molecular Mutagenesis | Steven W. Kohler, Gabrielle S. Le Provost et al. | 171 |
| 10 | Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state. | Proceedings of the National Academy of Sciences | Ernest Beutler, Terri Gelbart et al. | 121 |
| 11 | Gene transfer in the treatment of hematologic disease. | PubMed | Ernest Beutler, Joseph A. Sorge | 6 |
| 12 | High level transcription of the glucocerebrosidase pseudogene in normal subjects and patients with Gaucher disease. | Journal of Clinical Investigation | Joseph A. Sorge, E A Gross et al. | 60 |
| 13 | Development of a short-term,in vivomutagenesis assay: the effects of methylation on the recovery of a lambda phage shuttle vector from transgenic mice | Nucleic Acids Research | Steven W. Kohler, Patricia L. Kretz et al. | 106 |
| 14 | Histopathology of α1–Antitrypsin Liver Disease in A Transgenic Mouse Model | Hepatology | Stephen A. Geller, Stephen Nichols et al. | 29 |
| 15 | The use of transgenic mice for short-term, in vivo mutagenicity testing | PubMed | Steven W. Kohler, Gabrielle S. Le Provost et al. | 69 |
| 16 | Retroviral-mediated transfer and expression of hepatitis B e antigen in human primary skin fibroblasts and Esptein-Barr virus-transformed B lymphocytes | Virology | Anneke K. Raney, David R. Milich et al. | 10 |
| 17 | λ ZAP: a bacteriophage λ expression vector within vivoexcision properties breakdown → | Nucleic Acids Research | Jay M. Short, Joseph M. Fernandez et al. | 1261 |
| 18 | An Embryonic DNA-Binding Protein Specific for the Promoter of the Retrovirus Long Terminal Repeat | Molecular and Cellular Biology | Frédéric Flamant, Joseph A. Sorge et al. | 12 |
| 19 | Transfection of a factor-dependent cell line with the murine interleukin-3 (IL-3) cDNA results in autonomous growth and tumorigenesis | Leukemia Research | Frank R. Jirik, Joseph A. Sorge et al. | 6 |
| 20 | Splicing of intervening sequences introduced into an infectious retroviral vector. | PubMed | Joseph A. Sorge, Stephen H. Hughes | 53 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.